Overlap of Anxiety and Depression in a Managed Care Population: Prevalence and Association With Resource Utilization
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
OBJECTIVE: To characterize the diagnosis of anxiety and depression within a large managed care population and to measure the impact of having both of these conditions on treatment patterns, health care utilization, and cost. Further, to compare the impact of having both conditions with having neither or either condition alone. METHOD: A retrospective, cross-sectional analysis of population-level anxiety-related and depression-related utilization over a 12-month study period was conducted. Data were from the PharMetrics Patient-Centric database, which is composed of medical and pharmaceutical claims for approximately 36 million patients from 61 health plans across the United States. Patients 18 years and older were included as cases in the analysis if they had a diagnosis of depression or anxiety during 2002. Four groups were identified based on the presence of anxiety and/or depression diagnosis: anxiety only, depression only, anxiety and depression, and controls. Controls were matched to the anxiety and depression cohort using a 4:1 ratio, based on patient age, gender, and similarity of health coverage. Cohorts were compared with respect to patient demographics, comorbid diagnoses, medication use, specialist care, utilization of health care services, and treatment costs, using both univariate and multivariate statistics. RESULTS: Significant differences in comorbid diagnoses, medication use, health care utilization, and treatment costs existed between the study groups. Specifically, patients with both anxiety and depression tended to have more somatic complaints such as abdominal pain, malaise, or chest pain than patients with either condition alone or the control group. Antidepressant use was highest among the anxiety and depression cohort, while anxiolytic use was as prevalent in the anxiety and depression cohort as in the anxiety only cohort. Patients in the anxiety only, depression only, or anxiety plus depression groups had a higher number of anxiety- and/or depression-related visits as well as visits not related to depression or anxiety than the control group, with the anxiety and depression cohort incurring the highest utilization of medical services. Similarly, in terms of cost, the disease cohorts incurred significantly higher cost than their control counterparts, with the anxiety and depression cohort incurring higher cost than those with either condition alone, even after accounting for differences in patient characteristics. CONCLUSIONS: Combination of anxiety and depression is fairly common in a managed care population as evidenced by diagnosis and treatment. The combination of both diagnoses appears to increase the complexity of these patients with respect to comorbid conditions as well as increases the economic cost to payers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, depression and anxiety frequently co-occur.3-5;10-16”
From Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials (2016) · cites this paper as [16]
Citations
Cites
Still being checked.
Cited by
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Kessler, R. C., Sampson, N. A., Berglund, P., Gruber, M. J., Al-Hamzawi, A., Andrade, L., Bunting, B., Demyttenaere, K., Florescu, S., de Girolamo, G., et al. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000189 · Cited by 636
“…that MDD is highly comorbid with numerous anxiety disorders (Andrade et al. 2003; Kessler et al. 2011b; Lamers et al. 2011) and more severe and persistent when accompanied by comorbid anxiety disorders (Ormel et al. 1994; Roy-Byrne et al. 2000; McLaughlin et al. 2006; Fichter et al. 2010).”
BackgroundResultBair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318185c510 · Cited by 572
“03 high school 120 (44) 4 (27) 36 (37) 34 (30) Employment, n (%) Employed 56 (21) 5 (33) 19 (19) 37 (32) .”
BackgroundKroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000322 · Cited by 504
Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.4.383 · Cited by 364
Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y.-K., & Jeon, H. J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 304
Sterling, L., Dawson, G., Estes, A., & Greenson, J. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0477-y · Cited by 263
Anxiety disorders and healthcare utilization: A systematic review
Horenstein, A., & Heimberg, R. G. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101894 · Cited by 183
Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: A systematic review
Konnopka, A., Leichsenring, F., Leibing, E., & König, H.-H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.014 · Cited by 161
“On the other hand, all databases used by retrospective cohort studies were Table 2 Cost categories considered by cost-of-illness studies Study Direct cost Outpatient treatment Inpatient treatment Drugs Rehabilitations Em unit Edlund and Swan (1987) + − − − − Siegel et al. (1990) + − − − + Souetre et al. (1994) + + + −…”
BackgroundInfluentialGaynes, B. N., Pence, B. W., Eron, J. J., & Miller, W. C. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816aa0cc · Cited by 143
The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care
Ekman, M., Granström, O., Omérov, S., Jacob, J., & Landén, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.003 · Cited by 101
Approach to the Patient with Multiple Somatic Symptoms
Croicu, C., Chwastiak, L., & Katon, W. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.007 · Cited by 81
Zhu, B., Zhao, Z., Ye, W., Marciniak, M. D., & Swindle, R. (2009) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181963486 · Cited by 32
“Patients with GAD have been reported to incur higher annual medical costs than those without GAD diagnosis (Chang et al., 2005, McLaughlin et al., 2006).”
BackgroundExercise for the Management of Anxiety and Stress-Related Disorders
Herring, M. P. (2018) · Exercise-Based Interventions for Mental Illness · doi:10.1016/b978-0-12-812605-9.00002-2 · Cited by 15
Interpersonal psychotherapy and mindfulness for treatment of major depression with anxious distress
Mahan, R. M., Swan, S. A., & Macfie, J. (2018) · Clinical Case Studies · doi:10.1177/1534650118756530 · Cited by 12
Metadata
- Authors
- McLaughlin, T. P., Khandker, R. K., Kruzikas, D. T., & Tummala, R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-08-15
- Volume
- 67
- Issue
- 08
- Pages
- 1187-1193
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1975549116
- Cited by
- 105
- References
- 0
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 8 · 2017: 2 · 2016: 9 · 2015: 7 · 2014: 3 · 2013: 9 · 2012: 4
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- anxiety, depression, comorbidities, managed care, health care utilization, health care costs, antidepressant use, anxiolytic use, somatic symptoms, psychiatric diagnosis, medication use
- MeSH terms
- Adolescent, Adult, Anxiety Disorders, Depressive Disorder, Drug Utilization, Emergency Medical Services, Female, Health Services, Hospitalization, Humans, Insurance Claim Reporting, Male, Managed Care Programs, Middle Aged, Cohort Studies, Comorbidity, Prevalence, Multivariate Analysis, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.